New diabetes clinical trial: Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State
Published on: 2026-05-06T04:00:00Z Conditions : Hypertension; Diabete Type 2 Interventions : Drug: Test group 1; Drug: Test group 2 Sponsors : Hanlim Pharm. Co., Ltd. Completed https://ift.tt/SXcF9nj